H-1B sponsorship profile: Blueprint Medicines Corporation. Across U.S. Department of Labor LCA disclosures, Blueprint Medicines Corporation filed 37 Labor Condition Applications covering 37 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (37 certified of 37 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Blueprint Medicines Corporation’s H-1B petitions range from $93,610 at the low end to $238,013 at the high end, with a petition-weighted average of $156,758. That range reflects the mix of occupations the company sponsors, led by Scientist II, Analytical Development (4 petitions at $147,772 avg), followed by Senior Scientist, Pharmacovigilance and Senior Manager Drug Safety and Pharmacovigilance Operations. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Blueprint Medicines Corporation is headquartered in Cambridge, MA under NAICS code 541714, and places H-1B workers across 5 states, most heavily in MA, CA, PA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Blueprint Medicines Corporation ranks. By H-1B petition volume, Blueprint Medicines Corporation is #6,152 of 119,880 employers nationally and #266 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.